Role of human leukocyte antigen class I alleles in progressive multifocal leukoencephalopathy

References

• Bohl DL, Storch GA, Ryschkewitsch C, Gaudreault-Keener M, Schnitzler MA, Major EO, Brennan DC. (2005). Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am J Transplant 5: 2213–2221.
   PubMed Web of Science ®Google Scholar
• Carrington M, Nelson GW, Martin MP, Kissner T, Vlahov D, Goedert JJ, Kaslow R, Buchbinder S, Hoots K, O'Brien SJ. (1999). HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 283: 1748–1752.
   PubMed Web of Science ®Google Scholar
• Carrington M, O'Brien SJ. (2003). The influence of HLA genotype on AIDS. Annu Rev Med 54: 535–551.
   PubMed Web of Science ®Google Scholar
• Carson KR, Evens AM, Richey EA, Habermann TM, Focosi D, Seymour JF, Laubach J, Bawn SD, Gordon LI, Winter JN, Furman RR, Vose JM, Zelenetz AD, Mamtani R, Raisch DW, Dorshimer GW, Rosen ST, Muro K, Gottardi-Littell NR, Talley RL, Sartor O, Green D, Major EO, Bennett CL. (2009). Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood 113: 4834–4840.
   PubMed Web of Science ®Google Scholar
• Chang LY, Chang IS, Chen WJ, Huang YC, Chen GW, Shih SR, Juang JL, Shih HM, Hsiung CA, Lin TY, Huang LM. (2008). HLA-A33 is associated with susceptibility to enterovirus 71 infection. Pediatrics 122: 1271–1276.
   PubMed Web of Science ®Google Scholar
• Chen Y, Trofe J, Gordon J, Du Pasquier RA, Roy-Chaudhury P, Kuroda MJ, Woodle ES, Khalili K, Koralnik IJ. (2006). Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy. J Virol 80: 3495–3505.
   PubMed Web of Science ®Google Scholar
• Cinque P, Koralnik IJ, Clifford DB. (2003). The evolving face of human immunodeficiency virus-related progressive multifocal leukoencephalopathy: defining a consensus terminology. J NeuroVirol 9(Suppl 1): 88–92.
   Google Scholar
• Cooke GS, Hill AV. (2001). Genetics of susceptibility to human infectious disease. Nat Rev Genet 2: 967–977.
   PubMed Web of Science ®Google Scholar
• Dorak MT, Tang J, Tang S, Penman-Aguilar A, Coutinho RA, Goedert JJ, Detels R, Kaslow RA. (2003). Influence of human leukocyte antigen-B22 alleles on the course of human immunodeficiency virus type 1 infection in 3 cohorts of white men. J Infect Dis 188: 856–863.
   Google Scholar
• Du Pasquier RA, Kuroda MJ, Schmitz JE, Zheng Y, Martin K, Peyerl FW, Lifton M, Gorgone D, Autissier P, Letvin NL, Koralnik IJ. (2003). Low frequency of cytotoxic T lymphocytes against the novel HLA-A*0201-restricted JC virus epitope VP1(p36) in patients with proven or possible progressive multifocal leukoencephalopathy. J Virol 77: 11918–11926.
   PubMed Web of Science ®Google Scholar
• Du Pasquier RA, Kuroda MJ, Zheng Y, Jean-Jacques J, Letvin NL, Koralnik IJ. (2004). A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy. Brain 127: 1970–1978.
   PubMed Web of Science ®Google Scholar
• Friese MA, Jakobsen KB, Friis L, Etzensperger R, Craner MJ, McMahon RM, Jensen LT, Huygelen V, Jones EY, Bell JI, Fugger L. (2008). Opposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis. Nat Med 14: 1227–1235.
   PubMed Web of Science ®Google Scholar
• Gao X, Nelson GW, Karacki P, Martin MP, Phair J, Kaslow R, Goedert JJ, Buchbinder S, Hoots K, Vlahov D, O'Brien SJ, Carrington M. (2001). Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med 344: 1668–1675.
   PubMed Web of Science ®Google Scholar
• Garrett TP, Saper MA, Bjorkman PJ, Strominger JL, Wiley DC. (1989). Specificity pockets for the side chains of peptide antigens in HLA-Aw68. Nature 342: 692–696.
   PubMed Web of Science ®Google Scholar
• Genentech. (2009). Genentech announces voluntary withdrawal of Raptiva from the U.S. market. South San Francisco, CA: Genentech.
   Google Scholar
• Hill AV, Allsopp CE, Kwiatkowski D, Anstey NM, Twumasi P, Rowe PA, Bennett S, Brewster D, McMichael AJ, Greenwood BM. (1991). Common west African HLA antigens are associated with protection from severe malaria. Nature 352: 595–600.
   PubMed Web of Science ®Google Scholar
• Hill AV, Yates SN, Allsopp CE, Gupta S, Gilbert SC, Lalvani A, Aidoo M, Davenport M, Plebanski M. (1994). Human leukocyte antigens and natural selection by malaria. Philos Trans R Soc Lond B Biol Sci 346: 379–385.
   Google Scholar
• Ivic I, Bradaric N, Puizina-Ivic N, Ledina D, Luksic B, Martinic R. (2007). Hla-Cw7 allele as predictor of favorable therapeutic response to interferon-alpha in patients with chronic hepatitis C. Croat Med J 48: 807–813.
   Google Scholar
• Koralnik IJ. (2006). Progressive multifocal leukoencephalopathy revisited: has the disease outgrown its name? Ann Neurol 60: 162–173.
   PubMed Web of Science ®Google Scholar
• Koralnik IJ, Du Pasquier RA, Kuroda MJ, Schmitz JE, Dang X, Zheng Y, Lifton M, Letvin NL. (2002). Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope. J Immunol 168: 499–504.
   PubMed Web of Science ®Google Scholar
• Lopez-Vazquez A, Rodrigo L, Mina-Blanco A, Martinez-Borra J, Fuentes D, Rodriguez M, Perez R, Gonzalez S, Lopez-Larrea C. (2004). Extended human leukocyte antigen haplotype EH18.1 influences progression to hepatocellular carcinoma in patients with hepatitis C virus infection. J Infect Dis 189: 957–963.
   Google Scholar
• Marzocchetti A, Tompkins T, Clifford DB, Gandhi RT, Kesari S, Berger JR, Simpson DM, Prosperi M, De Luca A, Koralnik IJ. (2009). Determinants of survival in progressive multifocal leukoencephalopathy. Neurology 73: 1551–1558.
   PubMed Web of Science ®Google Scholar
• McAulay KA, Higgins CD, Macsween KF, Lake A, Jarrett RF, Robertson FL, Williams H, Crawford DH. (2007). HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection. J Clin Invest 117: 3042–3048.
   PubMed Web of Science ®Google Scholar
• McKiernan SM, Hagan R, Curry M, McDonald GS, Kelly A, Nolan N, Walsh A, Hegarty J, Lawlor E, Kelleher D. (2004). Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source. Hepatology 40: 108–114.
   PubMed Web of Science ®Google Scholar
• Muller-Hilke B, Mitchison NA. (2006). The role of HLA promoters in autoimmunity. Curr Pharm Des 12: 3743–3752.
   PubMed Web of Science ®Google Scholar
• Salter RD, Norment AM, Chen BP, Clayberger C, Krensky AM, Littman DR, Parham P. (1989). Polymorphism in the alpha 3 domain of HLA-A molecules affects binding to CD8. Nature 338: 345–347.
   PubMedGoogle Scholar
• Schreuder GM, Hurley CK, Marsh SG, Lau M, Fernandez-Vina M, Noreen HJ, Setterholm M, Maiers M. (2005). The HLA Dictionary 2004: a summary of HLA-A, -B, -C, -DRB1/3/4/5 and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. Int J Immunogenet 32: 19–69.
   PubMed Web of Science ®Google Scholar
• Thio CL, Gao X, Goedert JJ, Vlahov D, Nelson KE, Hilgartner MW, O'Brien SJ, Karacki P, Astemborski J, Carrington M, Thomas DL. (2002). HLA-Cw*04 and hepatitis C virus persistence. J Virol 76: 4792–4797.
   PubMed Web of Science ®Google Scholar
• Thio CL, Thomas DL, Karacki P, Gao X, Marti D, Kaslow RA, Goedert JJ, Hilgartner M, Strathdee SA, Duggal P, O'Brien SJ, Astemborski J, Carrington M. (2003). Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection. J Virol 77: 12083–12087.
   PubMed Web of Science ®Google Scholar
• Thursz MR, Kwiatkowski D, Allsopp CE, Greenwood BM, Thomas HC, Hill AV. (1995). Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med 332: 1065–1069.
   PubMed Web of Science ®Google Scholar